Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gouin

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Annales De Biologie Clinique|December 1, 2000
[Venous thrombosis and cancer]I Gouin-Thibaut, M M Samama
Seminars in Thrombosis and Hemostasis|June 5, 1999
Laboratory diagnosis of the thrombophilic state in cancer patientsI Gouin-Thibault, M M Samama
Annales De Biologie Clinique|October 7, 2000
[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time]A Kher, I Gouin, M M Samama
Drugs|January 1, 1996
New data on the pharmacology of heparin and low molecular weight heparinsM M Samama, L Bara, I Gouin-Thibault
Acta Haematologica|September 11, 2001
The thrombophilic state in cancer patientsI Gouin-Thibault, A Achkar, M M Samama
Journal of Thrombosis and Haemostasis : JTH|August 9, 2011
No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudyV Siguret, I Gouin-Thibault, E Pautas, et al.
Journal Des Maladies Vasculaires|March 18, 2015
[Management of direct oral anticoagulants for invasive procedures]A Godier, I Gouin-Thibault, N Rosencher, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1990
[Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients]I Gouin, M H Horellou, J Conard, et al.
British Journal of Haematology|July 1, 1995
Measurement of factor Xa-antithrombin III in plasma: relationship to prothrombin activation in vivoI Gouin-Thibault, L Dewar, M Kulczycky, et al.
Presse Medicale (Paris, France : 1983)|July 24, 2003
[Excess antivitamin K in elderly hospitalised patients aged over 70. A one-year prospective survey]V Siguret, C Esquirol, M Debray, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Annales De Biologie Clinique|December 1, 2000
[Venous thrombosis and cancer]I Gouin-Thibaut, M M Samama
Seminars in Thrombosis and Hemostasis|June 5, 1999
Laboratory diagnosis of the thrombophilic state in cancer patientsI Gouin-Thibault, M M Samama
Annales De Biologie Clinique|October 7, 2000
[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time]A Kher, I Gouin, M M Samama
Drugs|January 1, 1996
New data on the pharmacology of heparin and low molecular weight heparinsM M Samama, L Bara, I Gouin-Thibault
Acta Haematologica|September 11, 2001
The thrombophilic state in cancer patientsI Gouin-Thibault, A Achkar, M M Samama
Journal of Thrombosis and Haemostasis : JTH|August 9, 2011
No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudyV Siguret, I Gouin-Thibault, E Pautas, et al.
Journal Des Maladies Vasculaires|March 18, 2015
[Management of direct oral anticoagulants for invasive procedures]A Godier, I Gouin-Thibault, N Rosencher, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1990
[Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients]I Gouin, M H Horellou, J Conard, et al.
British Journal of Haematology|July 1, 1995
Measurement of factor Xa-antithrombin III in plasma: relationship to prothrombin activation in vivoI Gouin-Thibault, L Dewar, M Kulczycky, et al.
Presse Medicale (Paris, France : 1983)|July 24, 2003
[Excess antivitamin K in elderly hospitalised patients aged over 70. A one-year prospective survey]V Siguret, C Esquirol, M Debray, et al.
Pageof 3